Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.95 EUR | -0.07% | +2.72% | -0.43% |
May. 03 | European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower | MT |
May. 03 | FRESENIUS SE : Buy rating from Barclays | ZD |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.68 for the current year.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- One of the major weak points of the company is its financial situation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.43% | 16.85B | A- | ||
+13.70% | 81.68B | C+ | ||
-29.20% | 69.23B | B- | ||
+9.72% | 29.08B | C+ | ||
-11.43% | 16.88B | B | ||
-0.31% | 15.15B | A- | ||
+3.42% | 12.62B | A- | ||
+28.34% | 12.47B | B- | ||
-30.70% | 11.89B | - | - | |
-6.75% | 11.68B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- FRE Stock
- Ratings Fresenius SE & Co. KGaA